Advisory Committee Tracker: ODAC Is Back, With Two AZ Applications Set For Review April 30 Including Potential ctDNA Milestone; Still No Others On FDA’s Agenda

You must be a logged-in member of this site to view this article.

To request more information about a company license to the Prevision Policy continuous information service or to get further details about the services we offer, please click here.

Alternatively, if your organization already has a license and you do not yet have an account, please click here to request access.